enGene Therapeutics (ENGN) Liabilities and Shareholders Equity (2022 - 2026)
enGene Therapeutics (ENGN) posted Liabilities and Shareholders Equity of $288.32 million for fiscal Q3 2026 (quarter ended Jul 31, 2026), up 17.4% from $245.55 million a year earlier but down 6.2% from the prior quarter.
Powered by 
Analysis
enGene Therapeutics (ENGN) Liabilities and Shareholders Equity (2022 - 2026) Analysis & Trends
At the end of FY2025 (ended Oct 31, 2025), enGene Therapeutics' Liabilities and Shareholders Equity came in at $221.47 million, down 28.8% from FY2024.
- Annual Liabilities and Shareholders Equity shows a three-year compound annual growth rate of 110.0% (FY2022 to FY2025).
- In prior fiscal years, enGene Therapeutics' Liabilities and Shareholders Equity was $311.17 million in FY2024 (+257.8%), $86.96 million in FY2023 (+263.7%) and $23.91 million in FY2022.
- Quarterly Liabilities and Shareholders Equity has run from a low of $23.91 million in fiscal Q4 2022 to a high of $337.11 million in fiscal Q1 2026 over five years.
- On a year-over-year basis, Liabilities and Shareholders Equity has increased in each of the last three quarters, with growth averaging 59.4% over the last eight quarters.
- The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was fiscal Q4 2023, with growth of 263.7%; the weakest was fiscal Q4 2025, with a decline of 28.8%.
- According to Business Quant data, Liabilities and Shareholders Equity for the three prior fiscal quarters was $307.52 million (Q2 2026), $337.11 million (Q1 2026) and $221.47 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | enGene Therapeutics | 134.03 Mn | 134.03 Mn | - | 288.32 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 288.32 Mn |
| Apr 30, 2026 | 307.52 Mn |
| Jan 31, 2026 | 337.11 Mn |
| Oct 31, 2025 | 221.47 Mn |
| Jul 31, 2025 | 245.55 Mn |
| Apr 30, 2025 | 266.65 Mn |
| Jan 31, 2025 | 285.93 Mn |
| Oct 31, 2024 | 311.17 Mn |
| Jul 31, 2024 | 266.88 Mn |
| Apr 30, 2024 | 273.53 Mn |
| Jan 31, 2024 | 93.42 Mn |
| Oct 31, 2023 | 86.96 Mn |
| Oct 31, 2022 | 23.91 Mn |
API Access
enGene Therapeutics Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ENGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "ENGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ENGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();